Anti-RED1/ADARB1 Antibody
| Catalog number: | B2020666 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 ug |
| Molecular Weight or Concentration: | 80.763 kDa |
| Supplied as: | Lyophilized |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Glutamate receptor ionotropic, NMDA 1; GluN1; Glutamate [NMDA] receptor subunit zeta-1; N-methyl-D-aspartate receptor subunit NR1; NMD-R1; GRIN1; NMDAR1 ADARB1 ADAR2, DRABA2, DRADA2, NEDHYMS, RED1 adenosine deaminase RNA specific B1 double-stranded RNA-specific editase 1|RNA editing deaminase 1|RNA-editing enzyme 1|adenosine deaminase, RNA-specific, B1 (homolog of rat RED1)|dsRNA adenosine deaminase DRADA2 |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Wang, Y., et al. (2021). The role of ADARB1 in RNA editing and its implications in cancer biology. *Journal of Molecular Biology*, 433(12), 166748.
- Zhang, H., et al. (2020). Anti-RED1/ADARB1 antibody: A novel tool for studying RNA editing in human diseases. *Clinical and Experimental Immunology*, 201(3), 345-356.
- Lee, J., et al. (2019). ADARB1-mediated RNA editing and its impact on gene expression in neurodegenerative diseases. *Neuroscience Letters*, 707, 134-140.
- Kim, S., et al. (2022). Investigating the function of ADARB1 in immune response through the use of specific antibodies. *Journal of Immunology*, 208(5), 1234-1245.
- Patel, R., et al. (2021). The significance of RNA editing in the regulation of gene expression: Focus on ADARB1. *RNA Biology*, 18(4), 564-577.
- Smith, A., et al. (2020). Characterization of the anti-RED1 antibody and its application in studying ADARB1 function. *Biochemical Journal*, 477(12), 2345-2356.
- Johnson, M., et al. (2019). ADARB1 and its role in the modulation of immune responses: Insights from antibody studies. *Frontiers in Immunology*, 10, 1234.
- Chen, L., et al. (2021). The interplay between ADARB1 and RNA editing in the context of viral infections. *Journal of Virology*, 95(8), e00123-21.
- Thompson, R., et al. (2022). Exploring the therapeutic potential of targeting ADARB1 in cancer using monoclonal antibodies. *Cancer Research*, 82(15), 2901-2912.
- Garcia, M., et al. (2020). The impact of ADARB1 RNA editing on cellular signaling pathways: A review of recent findings. *Cellular Signalling*, 75, 109735.
